Ivabradine Tablet, Film Coated
Product Images NDC 72205-337

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ivabradine (NDC 72205-337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ivabradine-5mg-180s-cntr (Ivabradine 5mg 180s Cntr)

Ivabradine 5 mg film-coated tablets label for oral use, containing 180 tablets per package. Manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. The label includes storage instructions, dosage guidance, and barcode information.*

FDA Label Image

Ivabradine-5mg-60s-cntr (Ivabradine 5mg 60s Cntr)

Ivabradine Tablets 5 mg film-coated oral tablets label showing the product name, strength, and quantity of 60 tablets. The label indicates the medication is prescription only (Rx only) with NDC 72205-336-60. It includes storage instructions and manufacturer details, stating it is manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ.*

FDA Label Image

Ivabradine-7-5mg-180s-cntr (Ivabradine 7 5mg 180s Cntr)

Ivabradine Tablets 7.5 mg film-coated tablets label from Novadoz Pharmaceuticals LLC. The label states each tablet contains 7.5 mg ivabradine, equivalent to 8.085 mg ivabradine as hydrochloride, and comes in a bottle of 180 tablets. Storage instructions, barcode, and manufacturer details (MSN Laboratories Private Limited, India) are also visible.*

FDA Label Image

Ivabradine-7-5mg-60s-cntr (Ivabradine 7 5mg 60s Cntr)

Label for Ivabradine Tablets 7.5 mg film-coated tablets, distributed by Novadoz Pharmaceuticals LLC. The label states the dosage strength as 7.5 mg ivabradine per tablet, with 60 tablets per container. It includes storage instructions and contact information for the distributor, as well as a message directing pharmacists to dispense the medication guide to each patient.*

FDA Label Image

Ivabradine-figure-1 (Ivabradine Figure 1)

Chemical structure of Ivabradine hydrochloride, showing its molecular arrangement with aromatic rings, methoxy groups, nitrogen atoms, and associated hydrochloride (HCl).*

FDA Label Image

Ivabradine-figure-2 (Ivabradine Figure 2)

A chart showing fold change and 90% confidence intervals for pharmacokinetic measures (Cmax, AUC) of ivabradine when taken with various drugs. It categorizes drugs as strong/moderate CYP3A4 inhibitors, CYP3A4 inducers, and others. Recommendations range from contraindicated, avoid use, to no dose adjustment, based on interactions relative to ivabradine alone.*

FDA Label Image

Ivabradine-figure-3 (Ivabradine Figure 3)

A line graph comparing the proportion (%) of subjects with heart failure hospitalization or cardiovascular death over time (months) from randomization between Ivabradine and placebo groups. The graph includes the number of subjects at risk for each group at various time points up to 36 months.*

FDA Label Image

Ivabradine-figure-4 (Ivabradine Figure 4)

A forest plot comparing Ivabradine and placebo across various population subgroups, including age, sex, race, cause of heart failure, weight quartile, baseline heart rate quartile, NYHA class, baseline left ventricular ejection fraction quartile, baseline beta blocker and aldosterone antagonist use, diabetes status, and hypertension status. The plot shows hazard ratios (HR) and 95% confidence intervals (CI) for each subgroup with markers indicating effects favoring Ivabradine or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.